Posted on 11/17/20
Warren Buffett Bought 4 Pharma Giants in Q3
Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) filed its Form 13F with the Securities and Exchange Commission on Monday, which gave investors a look at what the Oracle of . . .
Posted on 11/17/20
Northern Westchester Orthopedist Shares Advice to Keep Back Pain at Bay as We Spend More Time at Home
As the weather starts getting colder, people who are spending more time at home due to the COVD pandemic find themselves leading an even more sedentary . . .
Posted on 11/16/20
Advent Technologies Collaboration With Los Alamos National Laboratory
NEW YORK--(BUSINESS WIRE)--AMCI Acquisition Corp. (NASDAQ: AMCI) today announced that Advent Technologies – with which AMCI has entered into a definitive agreement and plan of merger for . . .
Posted on 11/16/20
Pfizer Combine Its Upjohn Business with Mylan
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. . . .
Posted on 11/16/20
Frequency Therapeutics Provides Business Updates and Reports Third Quarter 2020 Financial Results
WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a . . .
Posted on 11/16/20
Regional Health Properties Reports Third Quarter 2020 Financial Results
ATLANTA--(BUSINESS WIRE)--Regional Health Properties, Inc. (NYSE American: RHE) (NYSE American: RHEpA), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for . . .
Posted on 11/16/20
scPharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
BURLINGTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to . . .
Posted on 11/16/20
Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
RESEARCH TRIANGLE PARK, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (Nasdaq:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK . . .
Posted on 11/16/20
Legend Biotech Reports Third Quarter 2020 Financial Results
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other . . .
Posted on 11/16/20
Nereid Therapeutics Launches: ATP $50M Series A NewCo Co-Founded with Brangwynne
Apple Tree Partners (ATP), a leading life sciences venture firm, today announced the launch of Nereid Therapeutics, a company dedicated to discovering new disease treatments
Posted on 11/16/20
Cerevel Therapeutics Announces Third Quarter 2020 Financial Results and Key Business Highlights
BOSTON, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today . . .
Posted on 11/16/20
Is Novavax a Ticking Time Bomb for Investors?
Any time there's euphoria in investing circles, the clock starts counting down to when some hot stocks -- those that traders treated more like chips in . . .
Posted on 11/16/20
This Is What a Comcast-Walmart TV Partnership Would Really Be About
Cable giant Comcast (NASDAQ:CMCSA) and retailer Walmart (NYSE:WMT) may be teaming up to make television sets, according to recent reports from The Wall Street Journal.Neither company . . .
Posted on 11/16/20
Why You Shouldn't Ignore Johnson & Johnson
The year 2020 has been full of surprises. Growth stocks, which are usually the first to get battered during economic downturns, have performed exceptionally well, while . . .
Posted on 11/16/20
These 3 Stocks Rallied 10% After Pfizer's Vaccine News: Here's Why They're Still Buys
Pfizer's Nov. 9 announcement that it's making progress toward a COVID-19 vaccine caused markets to rally, with beaten down sectors including airlines, industrials, and retailers leading . . .
Posted on 11/16/20
Here's Why Pfizer's Coronavirus Vaccine Would Be Revolutionary
Fool.com's Healthcare and Cannabis Bureau Chief Corinne Cardina interviewed Richard Horton on Motley Fool Live on Oct. 9. Horton runs the British medical journal The Lancet . . .
Posted on 11/16/20
The Biggest Takeaway From Pfizer's Coronavirus Vaccine Results
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) created a firestorm (in a good way) when they announced interim efficacy results for their coronavirus vaccine candidate BNT162b2 last Monday. Motley Fool . . .
Posted on 11/16/20
Karyopharm Therapeutics: Current Share Price Under-Reflects The Inherent Value
SummaryRecent advancements in readouts for Xpovio and Selinexor have yet to be reflected in market pricing, in our view.Karyopharm has had an in line quarter, where . . .
Posted on 11/16/20
Moderna Finishes Initial Data Collection in Coronavirus Vaccine Trial; Results Could Be Published Soon
Moderna (NASDAQ:MRNA) is now very close to publishing the first results of the crucial late-stage clinical trial for mRNA-1273, the company's COVID-19 vaccine candidate.The company revealed . . .
Posted on 11/16/20
What if Moderna Doesn't Win the Coronavirus Vaccine Race?
Key Points Moderna and rival Pfizer expect phase 3 safety readouts later this month.Pfizer this week said interim phase 3 efficacy data show its vaccine candidate . . .
Posted on 11/15/20
MyMD Pharmaceuticals, Akers Biosciences Merging to Form Baltimore-based Company
A merger deal between medical device companies will a result in a new Baltimore-based company with a
Posted on 11/13/20
EyeMD EMR to Debut Electronic Medical Records Software at AAO Virtual Conference
EyeMD EMR Healthcare Systems Inc., a leading provider of Electronic Medical Records (EMR) software designed specifically for ophthalmologists, will debut EyeMD EMR 2.0, an all-in-one EMR, . . .
Posted on 11/13/20
Moleculin Biotech Reports Financial Results for the Quarter Ended September 30, 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and . . .
Posted on 11/13/20
Milestone Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Corporate Update
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the third quarter . . .
Posted on 11/13/20
Cassava Sciences Pricing of $75 Million Public Offering of Common Stock
AUSTIN, Texas, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced the pricing of . . .

